Cigna (CI) Stock May Still Be A Bargain After Lead To One Vision
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Cigna Group's stock has seen a 48.5% gain over the past five years, prompting a review of whether its current price is justified by its earnings. Trading at a P/E ratio of 12.2x, Cigna is discounted compared to the broader healthcare sector and its peers, suggesting it may be undervalued based on earnings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.